On December 16, Glonghui announced that MicroPort NeuroTech (02172.HK) entered into a partnership agreement on December 16, 2024, with the Shenzhen Guidance Fund, Guangming District Guidance Fund, Shenzhen Smart Park, CICC Pu Cheng, Shenzhen Kangrui, CICC Capital, and CICC Ruishi to establish an investment fund. The total capital contribution by all partners under the partnership agreement amounts to RMB 1000 million, of which MicroPort NeuroTech (Shanghai) contributed RMB 200 million. After its establishment, the investment fund will be owned 20% by MicroPort NeuroTech (Shanghai), and it will not become a subsidiary of the company.
The investment fund will engage in private equity investments, asset management services, and other investment management services. All investments made by the fund will belong to the Medical and Asia Vets industries.
The company has become one of the leading firms in the field of neurointerventional therapy and has been looking for opportunities to expand its Business into Medical and other related areas. The investment fund aims to support the development of the Medical and Asia Vets industries, which aligns with the company's future development direction. Therefore, the Board of Directors believes that establishing the investment fund will support the company's diversified Global Strategy Business plan and enhance the company's competitiveness in the leading Medical-related industries.
